Rigel Pharmaceuticals, Inc. (RIGL)

42.05 +0.83 (+2.01%) USD  |  NASDAQ  |  Dec 11, 16:00
42.07 +0.02 (+0.05%) After-Hours: 20:00
More

Rigel Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. --
Perspective Therapeutics, Inc. Upgrade
Nektar Therapeutics --